logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9303029 B1

PDFFull Text
Date of Patent:
Apr. 05, 2016

Filed:

Oct. 26, 2012

Substituted quinoxalines as fgfr kinase inhibitors

Applicant:

Astex Therapeutics Limited, Cambridge, GB;

Inventors:

Steven John Woodhead, San Diego, CA (US);

Christopher William Murray, Cambridge, GB;

Valerio Berdini, Cambridge, GB;

Gordon Saxty, Zagreb, HR;

Gilbert Ebai Besong, Bad Duerkheim, DE;

Lieven Meerpoel, Beerse, BE;

Olivier Alexis Georges Querolle, Saint-Vigor, FR;

Virginie Sophie Poncelet, Le Manoir, FR;

Assignee:

ASTEX THERAPEUTICS LTD, Cambridge, GB;

Attorney:

Heslin Rothenberg Farley & Mesiti P.C.

Primary Examiner:

Douglas M Willis

Int. Cl.
CPC ...
A61K 31/498 (2006.01); C07D 241/42 (2006.01); C07D 471/04 (2006.01); C07D 403/12 (2006.01); C07D 401/14 (2006.01); C07D 413/14 (2006.01); C07D 401/04 (2006.01); C07D 401/06 (2006.01); C07D 401/12 (2006.01); C07D 403/04 (2006.01); C07D 403/06 (2006.01); C07D 407/04 (2006.01); C07D 407/14 (2006.01); C07D 413/04 (2006.01); C07D 417/04 (2006.01); C07D 241/44 (2006.01); C07D 417/12 (2006.01); A61K 31/4985 (2006.01); A61K 31/506 (2006.01); A61K 45/06 (2006.01); C07D 405/04 (2006.01); C07D 405/14 (2006.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); A61K 31/498 (2013.01); A61K 31/4985 (2013.01); A61K 31/506 (2013.01); A61K 45/06 (2013.01); C07D 241/42 (2013.01); C07D 241/44 (2013.01); C07D 401/04 (2013.01); C07D 401/06 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 403/04 (2013.01); C07D 403/06 (2013.01); C07D 403/12 (2013.01); C07D 405/04 (2013.01); C07D 405/14 (2013.01); C07D 407/04 (2013.01); C07D 407/14 (2013.01); C07D 413/04 (2013.01); C07D 413/14 (2013.01); C07D 417/04 (2013.01); C07D 417/12 (2013.01);
Abstract

The invention relates to new quinoxaline derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.

Find Patent Forward Citations

Woodhead, Steven. (2016). Substituted quinoxalines as fgfr kinase inhibitors (U.S. Patent No. 9303029). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9303029

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…